{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+%28placebo%29&page=7", "query": { "intervention": "Vehicle (placebo)", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 810, "total_pages": 81, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+%28placebo%29&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+%28placebo%29&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T08:31:14.904Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03210740", "title": "Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Actinic Keratosis" ], "interventions": [ { "name": "AM001 Cream, 7.5%", "type": "DRUG" }, { "name": "Vehicle Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AmDerma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 30, "start_date": "2017-06-06", "completion_date": "2018-04-24", "has_results": false, "last_update_posted_date": "2019-04-30", "last_synced_at": "2026-10-09T08:31:14.904Z", "location_count": 1, "location_summary": "High Point, North Carolina", "locations": [ { "city": "High Point", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03210740" }, { "nct_id": "NCT02029716", "title": "RTA 408 Lotion in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "RTA 408 Lotion 0.5%, 1%, 3%", "type": "DRUG" }, { "name": "Lotion vehicle/placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 109, "start_date": "2013-12-31", "completion_date": "2014-04-01", "has_results": false, "last_update_posted_date": "2025-05-28", "last_synced_at": "2026-10-09T08:31:14.904Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02029716" }, { "nct_id": "NCT00128245", "title": "Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Keratoconjunctivitis Sicca" ], "interventions": [ { "name": "Pimecrolimus", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 440, "start_date": "2004-09", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2020-05-27", "last_synced_at": "2026-10-09T08:31:14.904Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00128245" }, { "nct_id": "NCT02516202", "title": "The Vaginal Health Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrophy of Vagina", "Menopause", "Dyspareunia (Female)" ], "interventions": [ { "name": "Vagifem", "type": "DRUG" }, { "name": "Replens", "type": "DEVICE" }, { "name": "Placebo tablet", "type": "OTHER" }, { "name": "Placebo gel", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DEVICE", "OTHER" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "45 Years to 70 Years · Female only" }, "enrollment_count": 302, "start_date": "2016-04", "completion_date": "2017-07", "has_results": true, "last_update_posted_date": "2018-07-12", "last_synced_at": "2026-10-09T08:31:14.904Z", "location_count": 2, "location_summary": "Minneapolis, Minnesota • Seattle, Washington", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02516202" }, { "nct_id": "NCT00852839", "title": "A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dry Mouth Associated With Sjogren's Syndrome", "Xerostomia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "552-02", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Parion Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 140, "start_date": "2009-02", "completion_date": "2009-11", "has_results": false, "last_update_posted_date": "2018-09-18", "last_synced_at": "2026-10-09T08:31:14.904Z", "location_count": 15, "location_summary": "Trumbull, Connecticut • Gainesville, Florida • Indianapolis, Indiana + 12 more", "locations": [ { "city": "Trumbull", "state": "Connecticut" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Wheaton", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00852839" }, { "nct_id": "NCT00198445", "title": "Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Postoperative Complications", "Cataract" ], "interventions": [ { "name": "Bromfenac", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch & Lomb Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 527, "start_date": "2003-05", "completion_date": "2004-01", "has_results": false, "last_update_posted_date": "2013-03-14", "last_synced_at": "2026-10-09T08:31:14.904Z", "location_count": 39, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Irvine, California + 34 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Irvine", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00198445" }, { "nct_id": "NCT04663672", "title": "Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Claustrophobia", "Obsessive-Compulsive Disorder", "Arachnophobia" ], "interventions": [ { "name": "Experimental Scent", "type": "OTHER" }, { "name": "Control Scent", "type": "OTHER" }, { "name": "No-Scent Control", "type": "OTHER" }, { "name": "In-Vivo Exposure", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "University of Texas at Austin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 158, "start_date": "2019-01-29", "completion_date": "2020-03-01", "has_results": false, "last_update_posted_date": "2020-12-11", "last_synced_at": "2026-10-09T08:31:14.904Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04663672" }, { "nct_id": "NCT02091596", "title": "Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Foot Ulcer", "Infection" ], "interventions": [ { "name": "PluroGel N", "type": "DRUG" }, { "name": "PluroGel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PluroGen Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2013-10", "completion_date": "2014-09", "has_results": false, "last_update_posted_date": "2014-09-25", "last_synced_at": "2026-10-09T08:31:14.904Z", "location_count": 15, "location_summary": "Phoenix, Arizona • Los Angeles, California • Oakland, California + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Hamden", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02091596" }, { "nct_id": "NCT07160205", "title": "Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Idiopathic Inflammatory Myositis (IIM)", "DERMATOMYOSITIS OR POLYMYOSITIS" ], "interventions": [ { "name": "ULSC (1.5 x 10^8 cells/dose)", "type": "BIOLOGICAL" }, { "name": "Placebo (no cells)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Restem, LLC.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2026-01-06", "completion_date": "2029-08", "has_results": false, "last_update_posted_date": "2026-04-27", "last_synced_at": "2026-10-09T08:31:14.904Z", "location_count": 2, "location_summary": "Gainesville, Florida • Miami, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07160205" }, { "nct_id": "NCT00753402", "title": "The Effects of Epinephrine in Endotoxemia in Normal Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Immune System" ], "interventions": [ { "name": "Endotoxin, Lipopolysaccharide, LPS", "type": "BIOLOGICAL" }, { "name": "Endotoxin, Epinephrine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 37, "start_date": "2012-02", "completion_date": "2012-02", "has_results": false, "last_update_posted_date": "2015-05-27", "last_synced_at": "2026-10-09T08:31:14.904Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00753402" } ] }